Laboratory findings |
---|
Hematology | Â | Biochemistry | Â | Immunology | Â |
WBC | 12,590/µL | AST | 58 IU/L | HBsAg | (–) |
neut | 81.9% | ALT | 51 IU/L | HBsAb | (–) |
lym | 12.2% | ALP | 459 IU/L | HBcAb | (–) |
eosino | 0.7% | LDH | 169 IU/L | HCVAb | (–) |
mono | 4.1% | γ-GTP | 101 IU/L |  |  |
baso | 0.2% | TP | 7.2Â g/dL | Â | Â |
RBC | 404 × 104/µL | Alb | 2.9 g/dL |  |  |
Hb | 11.9Â g/dL | T-bil | 0.6Â mg/dL | Â | Â |
Hct | 37.6% | D-bil | 0.2Â mg/dL | Â | Â |
Plt | 57.5 × 104/µL | CRP | 15.8 mg/dL |  |  |
Tumor marker | Â | BUN | 11.7Â mg/dL | Â | Â |
CEA | 4Â ng/mL | Cre | 0.81Â mg/dL | Â | Â |
CA19-9 | 2.1Â U/mL | UA | 4.1Â mg/dL | Â | Â |
AFP | 1.3Â ng/mL | Na | 138Â mEq/L | Â | Â |
PIVKA-II | 12.9Â mAU/mL | K | 4.3Â mEq/L | Â | Â |
SCC | 18.6Â ng/mL | Cl | 102Â mEq/L | Â | Â |
CYFRA | 5.01Â ng/mL | PCT | 0.06Â ng/mL | Â | Â |
- WBC, white blood cell; neut, neutrophil; lym, lymphocyte; eosino, eosinophil; mono, monocyte; baso, basophil; RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; Plt, platelet; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19–9; AFP, alfa-fetoprotein; PIVKA-II, protein induced by vitamin K absence or antagonist-II; SCC, squamous cell carcinoma antigen; CYFRA, cytokeratin 19 fragment; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; γ-GTP, gamma-glutamyl transpeptidase; TP, total protein; Alb, albumin; T-bil, total bilirubin; D-bil, direct bilirubin; CRP, C-reactive protein; BUN, blood urea nitrogen; Cre, creatinine; UA, uric acid; Na, sodium; K, potassium; Cl, chlorine; PCT, procalcitonin; HBsAg, hepatitis B virus surface antigenemia; HBsAb, hepatitis B virus surface antibody; HBcAb, hepatitis B virus core antibody; HCVAb, hepatitis C virus antibody